BackMoonLake Immunotherapeutics Overview

MoonLake Immunotherapeutics Total Liabilities

Latest total liabilities for MLTX: $150M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$145.75M
↑ 42.68% YoYΔ $43.60M vs prior year quarter

Peer trimmed avg / median

Loading

MoonLake Immunotherapeutics Total Liabilities History

Loading

MoonLake Immunotherapeutics vs. peers: Total Liabilities Comparison

Loading

MoonLake Immunotherapeutics Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

MoonLake Immunotherapeutics (MLTX) FAQ

As of the most recent data (June 2026), MLTX shows a total liabilities of $150M. That compares with $100M in the prior-year period — up 42.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, MLTX's total liabilities is now $150M (was $100M) — a 42.7% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether MoonLake Immunotherapeutics is outperforming or lagging.

Tracking MLTX's total liabilities over time shows whether MoonLake Immunotherapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $150M That compares with $100M in the prior-year period — up 42.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has MoonLake Immunotherapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $150M) with ownership activity and broader fundamentals.